当前位置: 首页 > 期刊 > 《中国当代医药》 > 202018
编号:13834633
腹腔镜射频消融与腹腔镜肝切除治疗慢性乙型肝炎相关特殊部位原发性肝癌的临床效果比较(1)
http://www.100md.com 2020年6月25日 《中国当代医药》 202018
     [摘要]目的 評价腹腔镜射频消融(LRFA)与腹腔镜肝切除术(LH)治疗慢性乙型肝炎患者相关特殊部位原发性肝细胞癌(HCC)的效果及其安全性。方法 回顾性分析2012年1月~2017年12月广东医科大学附属医院收治的97例慢性乙型肝炎相关特殊部位HCC患者,共116个结节。根据不同的治疗方法分为两组,LRFA组(45例)行LRFA治疗,LH组(52例)采用LH方法,术后随访2年,比较两组总生存率、术后肝功能变化、住院时间及并发症发生率。结果 LRFA组术后瘤体完全消融率为100%。LRFA组术后1、2年总生存率为90.7%、84.0%,LH组为91.4%、82.5%,两组比较差异无统计学意义(P>0.05)。LRFA术后丙氨酸转氨酶水平低于LH组,差异有统计学意义(P<0.05)。LRFA组住院时间短于LH组,差异有统计学意义(P<0.05)。两组的并发症发生率比较,差异无统计学意义(P>0.05)。结论 LRFA与LH都是慢性乙型肝炎相关特殊部位HCC患者的根治方式,但是LRFA对肝功能损伤小,并发症发生率低,拓宽了射频消融的适用范围,对治疗特殊部位HCC更具优势。

    [关键词]慢性乙型肝炎;原发性肝细胞癌;腹腔镜手术;肝切除;射频消融;总生存率

    [中图分类号] R615 [文献标识码] A [文章编号] 1674-4721(2020)6(c)-0042-04

    Clinical effect comparison of laparoscopic radiofrequency ablation and laparoscopic hepatectomy in the treatment of chronic hepatitis B virus related special location small primary liver cancer

    DAI Wei MO Cong SHA Rong-gui DAI Jia-liang CAI Guan-he MIAO Hui-lai BAO Shi-ting CHEN Ming TAN Xiao-yu LI Ming-yi CHEN Nian-ping▲

    Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical University, Guangdong Province, Zhanjiang 524001,Chian

    [Abstract] Objective To evaluate the effect and safety of laparoscopic radiofrequency ablation (LRFA) and laparoscopic hepatectomy (LH) in the treatment of chronic hepatitis B virus related special location primary liver cancer. Methods A retrospective analysis of 97 patients with chronic hepatitis B-related special site HCC patients admitted to the Affiliated Hospital of Guangdong Medical University from January 2012 to December 2017 was made, a total of 116 nodules. According to different treatment methods, they were divided into two groups. LRFA group (45 cases) received LRFA treatment, LH group (52 cases) received LH method, and were followed up for 2 years after surgery. The overall survival rate, postoperativ, liver function changes, hospital stay and incidence of complications were compared between two groups. Results The complete ablation rate of tumors in the LRFA group was 100%. The 1- and 2-year overall survival rates in the LRFA group were 90.7% and 84.0%, and those in the LH group were 91.4% and 82.5%. There was no significant difference between the two groups (P>0.05). The level of alanine aminotransferase after LRFA was lower than that of LH group, the difference was statistically significant (P<0.05). The hospital stay in the LRFA group was shorter than that in the LH group, and the difference was statistically significant (P<0.05). The incidence of complications between the two groups was not statistically significant (P>0.05).Conclusion For chronic hepatitis B virus related special location small primary liver cancer, both LRFA and LH are effective. However, LRFA not only has less liver function damage and fewer complications, but also broadens the scope of application of radiofrequency ablation, which is more advantageous for treating special location liver cancer., http://www.100md.com(戴维 莫聪 沙荣贵 戴嘉良 蔡观河 缪辉来 包仕廷 陈明 谭小宇 李明意 陈念平)
1 2 3 4下一页